Conduit Pharmaceuticals Inc Share Price

NASDAQ: CDT

Small Cap

$0.89

+0.25

(+39.39%)

as on September 18, 2025 at 1:29 am IST

$₹

Conduit Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$0.81
Day's Price Range
$1.18
$0.89
8.99%
Downside
32.58%
Upside
52 Week's Low
52 Week's High
$0.57
52-Week Price Range
$274.8
$0.89
35.62%
Downside
30776.40%
Upside

Conduit Pharmaceuticals Inc share price movements today

Previous Close: $0.64
Open: $1.01
Volume: 205.8M
Day's Low - High: $0.81 - $1.18
52 Week Low - High: $0.57 - $274.8

Conduit Pharmaceuticals Inc Historical Returns

1 Month Return: -42.75 %
3 Month Return: -62.07 %
1 Year Return: -99.56 %
3 Year Return: 0 %
5 Year Return: 0 %

Conduit Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Conduit Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Conduit Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Conduit Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Conduit Pharmaceuticals Inc	NA	$2.0M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	248.74%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Conduit Pharmaceuticals Inc Stock including INR - Dollar returns

The Conduit Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Conduit Pharmaceuticals Inc investment value today

Current value as on today

₹5,037

Returns

₹94,963

(-94.96%)

Returns from Conduit Pharmaceuticals Inc Stock

₹99,561 (-99.56%)

Dollar Returns*

₹4,598 (+4.6%)

Conduit Pharmaceuticals Inc Stock's Interest Amongst Investors

Investment in Conduit Pharmaceuticals Inc Shares on INDmoney has grown by 214.81% over the past 30 days, indicating increased transactional activity.

Time period: August 19, 2025 to September 18, 2025

Change:214.81% versus previous 30 day period

Search interest for Conduit Pharmaceuticals Inc Stock has increased by 160% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:160% versus previous 30 day period

Conduit Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	535	604	654	1,076	624	671
Gross Profit	-	-	-	-	201	-695	244	249	0	258
Operating Income	-1	-1	0	0	-2	-3	-5	-3	-4	-4
EBITDA	-1	-1	1	1	-2	-5	-6	0	-4	-5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	0	0	0	0
Income Before Tax	-1	-1	2	1	-3	-5	-6	-2	-5	-6
Income Tax Expense	0	0	0	0	-8	-11	-60	0	-10	-5
Net Income	-1	-1	1	1	-3	-5	-6	-2	-5	-6
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-0.67%	-0.89%	-0.99%	-0.22%	-0.82%	-0.90%

Conduit Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	922
Gross Profit	-	-	-	0
Operating Income	0	-3	-5	-15
EBITDA	0	-4	0	-15
Interest Expense	-	-	0	1
Depreciation	-	-	-	0
Income Before Tax	0	-4	0	-17
Income Tax Expense	0	0	0	-29
Net Income	-3	-4	0	-17
Net Profit Margin	0.00%	0.00%	0.00%	-1.93%

Conduit Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	2	1	-3	-5	-6	-2	51	61
Operating Cash Flow	0	0	-4	-2	-1	-1	-3	7	82
Investing Cash Flow	0	0	0	-24	0	0	0	-24	-25
Financing Cash Flow	0	9	0	-64	0	1	4	-96	-19
Change in Cash	0	8	-4	-2	-1	0	0	-111	42

Conduit Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	0	-17
Operating Cash Flow	-2	-7	-9
Investing Cash Flow	0	0	0
Financing Cash Flow	2	10	6
Change in Cash	0	4	-3

Insights on Conduit Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, CDT stock has moved up by 49.8%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 168.0%

About Conduit Pharmaceuticals Inc

Conduit Pharmaceuticals, Inc. is a multi-asset clinical-stage, life science company. The Company facilitates the development and commercialization of clinical assets. The Company acquires and funds the development of Phase 2-ready assets, builds an integrated and advanced platform-driven approach powered by artificial intelligence (AI) and cybernetics, and seeks exit through third-party license deals following successful clinical trials. The Company’s asset pipeline includes AZD1656 (a Glucokinase Activator), AZD5658 (Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto’s Thyroiditis. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), for the treatment, prevention, and prophylaxis of idiopathic male infertility.

Organisation	Conduit Pharmaceuticals Inc
Headquarters	4581 Tamiami Trail North, Naples, FL, United States, 34103
CEO	Dr. Andrew Regan
E-voting on shares	Click here to vote

Key Management of Conduit Pharmaceuticals Inc

Name	Title
Dr. Andrew Regan	Founder, CEO & Director
Mr. James Bligh	Co-Founder, CFO & Director
Dr. Joanne M. Holland	Chief Scientific Officer

FAQs

What is Conduit Pharmaceuticals Inc share price today?

Conduit Pharmaceuticals Inc share price today is $0.89 as on September 18, 2025 at 1:29 am IST at the close of the market. Conduit Pharmaceuticals Inc share today touched a day high of $1.18 and a low of $0.81.

What is the 52 week high and 52 week low for Conduit Pharmaceuticals Inc share?

Conduit Pharmaceuticals Inc share touched a 52 week high of $274.8 on January 10, 2025 and a 52 week low of $0.57 on September 10, 2025. Conduit Pharmaceuticals Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $0.89,which is 99.68% down from its 52 week high and 55.32% up from its 52 week low.

What is Conduit Pharmaceuticals Inc's market capitalisation today?

Conduit Pharmaceuticals Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Conduit Pharmaceuticals Inc Stock (CDT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Conduit Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Conduit Pharmaceuticals Inc Shares that will get you 1.6854 shares as per Conduit Pharmaceuticals Inc share price of $0.89 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Conduit Pharmaceuticals Inc Stock (CDT) from India?

Indian investors can start investing in Conduit Pharmaceuticals Inc (CDT) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 3:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Conduit Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 3:41 pm IST). Based on Conduit Pharmaceuticals Inc share’s latest price of $0.89 as on September 18, 2025 at 1:29 am IST, you will get 11.2360 shares of Conduit Pharmaceuticals Inc. Learn more about fractional shares .